Anna Jachalska
Bydgoszcz, KP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: June 05, 2023
Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes.
Journal: Cells
Published: January 25, 2022
Autologous stem cell transplantation in the treatment of multiple myeloma with 17p deletion.
Journal: Polish archives of internal medicine
Published: January 15, 2020
18F-fluoro-ethyl-tyrosine (18F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study.
Journal: Contemporary oncology (Poznan, Poland)
Published: January 26, 2019
Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.
Journal: Leukemia research
Published: November 16, 2017
VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms.
Journal: Medicina (Kaunas, Lithuania)
Published: May 05, 2015
Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.
Journal: Leukemia research
Published: September 30, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026